James Rolke insider trades
Open-market stock purchases and sales by James Rolke, Chief Executive Officer at Revelation Biosciences, Inc, from SEC Form 4 filings since Jan 4, 2017.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 30, 2026 | REVB Revelation Biosciences, Inc | Sold (not open market) | $11.4K |
| Feb 3, 2026 | REVB Revelation Biosciences, Inc | Sold (not open market) | $15.8K |
| Jan 8, 2026 | REVB Revelation Biosciences, Inc | Bought (not open market) | $480K |
| Oct 29, 2025 | REVB Revelation Biosciences, Inc | Bought (not open market) | $500K |